UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6) has a total of 25 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Serbia. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are ANGIOGENE INC, UNIV PIERRE ET MARIE CURIE (PARIS 6) and MANSELL JOHN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 22 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Computer technology | |
#5 | Surface technology and coating |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Diagnosis and surgery | |
#4 | Electrotherapy | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Syringes | |
#8 | Processes for applying fluent materials | |
#9 | Image data processing | |
#10 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Morel Guillaume | 3 |
#2 | Carpentier Alexandre | 3 |
#3 | Boissiere Cédric | 3 |
#4 | Grosso David | 3 |
#5 | Canney Michael | 2 |
#6 | Sanchez Clément | 2 |
#7 | Benosman Ryad | 2 |
#8 | Vidal Clément | 2 |
#9 | Henri Patrick | 2 |
#10 | Cholvy Matthieu | 2 |
Publication | Filing date | Title |
---|---|---|
EP3272768A1 | Chimeric peptides useful in malaria prophylaxis or treatment | |
EP3243522A1 | Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death | |
EP3198102A1 | Active glazing system | |
EP3174972A1 | Method for in vitro production of adipocyte progenitors and adipocytes | |
EP3120897A1 | Method for downsampling a signal outputted by an asynchronous sensor | |
EP2789166A1 | Method of 3d reconstruction of a scene calling upon asynchronous sensors | |
EP2760361A1 | Device for guiding a medical instrument inserted into a natural duct or an artificial duct of a patient | |
EP2723360A1 | Ccr2 antagonist peptides | |
EP2406878A1 | Device for quickly generating a torque for an extended dynamic range with low inertia |